Skip to content

Early Postoperative Application of Radial Extracorporeal Shock Wave Therapy (rESWT) and Neuroreflectory Hyberbaric CO2 Cryotherapie Following Primary Reconstruction of the Anterior Cruciate Ligament: A Prospective, Randomized, Controlled Study

Early Postoperative Application of Radial Extracorporeal Shock Wave Therapy (rESWT) and Neuroreflectory Hyberbaric CO2 Cryotherapie Following Primary Reconstruction of the Anterior Cruciate Ligament: A Prospective, Randomized, Controlled Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038163
Enrollment
60
Registered
2025-10-29
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S83.53

Interventions

Group 1: Postoperative application of rESWT and HCT after ACL-reconstruction with standardized physiotherapy exercise program Group 2: Postoperative application of rESWT after ACL-reconstruction with

Sponsors

Sektion Sportorthopädie TUM Universitätsklinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: VKB injuries that are indicated for surgical treatment using a quadriceps tendon autograft

Exclusion criteria

Exclusion criteria: - Patients with injuries on the opposite side or other immobilizing injuries - Patients with recurrent injuries - Patients with higher-grade bone injuries, damage to the collateral ligament complex, meniscal root lesions, patellofemoral instability, cartilage damage, or higher-grade degenerative changes in the knee joint - Patients with underlying internal, oncological, or neurological diseases or generalized diseases of the musculoskeletal system - Patients with a history of vascular disease or DVT - Patients who have had intra-articular cortisone injections in the affected knee or have taken systemic steroids within the last 6 months - Previous knee joint injuries or knee operations with permanent functional impairment - Patients with cryoglobulinemia, Raynaud's syndrome, open wounds, or skin diseases in the area of the surgical site - Pregnancy or current desire to have children

Design outcomes

Primary

MeasureTime frame
IKDC score 12 weeks after surgery

Secondary

MeasureTime frame
Tegner activity scores, Lysholm scores, VAS pain scores, swelling status, and range of motion at 1, 3, 6, and 12 weeks postoperatively; IKDC score at 1, 3, and 6 weeks postoperatively

Countries

Germany

Contacts

Public ContactTobias Würfel

Sektion Sportorthopädie TUM Universitätsklinikum Rechts der Isar

tobias.wuerfel@mri.tum.de+498944009553

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026